Board and Executive Management

Board

Jörg-Michael Rupp, Roche (President)

Katharina Gasser, Biogen Switzerland AG (Vice President)

Nicholas Franco, Johnson & Johnson (Vice President)

Mark Never, Novartis (Vice President)

Henrik Asmussen, Amgen

Sabine Bruckner, Pfizer

René P. Buholzer, Interpharma (Delegate of the Board)

Jean-Luc Delay, Takeda

Christophe Griolet, Gilead Science

Remo Gujer, Bristol-Myers Squibb

Ans Heirman, MSD

Florian Ibe, Bayer

Matthias Leuenberger, Novartis

Andrea Michael Meyer, Sanofi

Nathalie Stieger, F. Hoffmann-La Roche

Mads Stoustrup, Novo Nordisk

Urs Vögeli, Johnson & Johnson

Christiane von der Eltz, Merck

Executive management

Dr. René P. Buholzer

Managing director

Susanne Müller

Member of the Executive Board / Services

Markus A. Ziegler

Member of the Executive Board / Innovation

Dr. Heiner Sandmeier

Deputy managing director / Markets

Yves Weidmann

Member of the Executive Board

Samuel Lanz

Head of Communications

Media contacts

Cécile Riviere

Communication Manager Romandie

Samuel Lanz

Head of Communications

Introducing Interpharma

Information on our key figures and activities in the financial year 2020

More about the tasks and overriding aims of Interpharma

Order and download publications.